Cognition Therapeutics, Inc.

CGTX·NasdaqCM·Healthcare
Compare
0.6833−0.0162 (−2.32%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market0.68330.0000 (0.00%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.6995
Open0.7199
Day range0.68000.7292
52-week range0.55001.8250
Off day high−6.29%
Off 52-week high−62.56%
Volume421.07K
Avg. volume (3M)508.61K
Market cap64.98M
EPS (TTM)-0.1700
Forward P/E-3.11
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.80
Shares outstanding95.09M
Short interest7.98% of float
Earnings dateNov 12, 2025 (est.)
Analyst target3.3333
Profit margin0.00%

Against its peers

Compare in full ›
CGTX ACOG GANX VYGR PMN CRVO
Market cap 64.98M 185.77M 48.44M 115.23M 31.57M 23.59M
P/E (TTM) — — — — — —
Forward P/E -3.1 -13.8 -1.6 -1.5 -0.8 -1.1
Price/book 2.0 3.5 4.3 0.7 0.6 0.9
Dividend yield — — — — — —
1-year change −58.86% +49.65% −41.58% −55.69% −63.90% −78.60%
Today −2.32% +4.02% −3.48% +2.19% +3.23% +0.65%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All CGTX news ›
ir.cogrx.com··2 outletsPositive

Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045

Investor Relations / Press Releases – An additional five years of patent protection may be possible through a standard extension – The ‘979 patent offers the following protections: The USAN Council has adopted zervimesine as the United…

More from 1 other outlet
Longevity.Technology·Positive

Cognition Therapeutics wins patent for zervimesine through 2045

The United States Patent and Trademark Office has granted Cognition Therapeutics a patent covering a novel crystalline form, or polymorph, of zervimesine (CT1812), U.S. Patent No. 12,759,979, with a natural expiration in 2045 and potential…

From the 4Search news index, newest first.

In the news

9mentions in 30 days
9with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance